Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational StudyJing Lian Suah, Sheamini Sivasampu, Maheshwara Rao Appannan et al.|International Journal of Infectious Diseases|2022Cited by 79
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infectionJing Lian Suah, Sheamini Sivasampu, Peter Seah Keng Tok et al.|Emerging Microbes & Infections|2022Cited by 57
PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine PortfolioJing Lian Suah, Kalaiarasu M. Peariasamy, Peter Seah Keng Tok et al.|Vaccines|2021Cited by 46
Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 MonthsEe Vien Low, Kalaiarasu M. Peariasamy, Peter Seah Keng Tok et al.|JAMA Network Open|2022Cited by 24
Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in MalaysiaMasliyana Husin, Sheamini Sivasampu, Peter Seah Keng Tok et al.|International Journal of Infectious Diseases|2022Cited by 20